KIORA PHARMACEUTICALS, INC. Tax Withholding Paid on Stock Awards
KIORA PHARMACEUTICALS, INC. (KPRX) reported Tax Withholding Paid on Stock Awards of $10.33 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $9.32K.
- KIORA PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $1.01K.
- KIORA PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-03-31 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month |
|---|---|---|
| 2026-06-30 | $9.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $10.33K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $1.01K 10-Q · filed 2026-05-08 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |